Sort   by:  
 Page size 
TranscriptomicsTuberculosis patients blood gene expression through treatment
Background Accurate assessment of treatment efficacy would facilitate clinical trials of new anti-tuberculosis drugs. TB patients exhibit altered peripheral immunity which reverts during successful treatment. We hypothesised that these changes could be observed in whole blood transcriptome profiles...
ORGANISM(S): Homo sapiens 
2012-08-09 | E-GEOD-31348 | biostudies-arrayexpress
TranscriptomicsTuberculosis Patients Blood Gene Expression Through Treatment (cured and end-of-treatment patients)
Background Accurate assessment of treatment efficacy would facilitate clinical trials of new anti-tuberculosis drugs. TB patients exhibit altered peripheral immunity which reverts during successful treatment. We hypothesised that these changes could be observed in whole blood transcriptome profiles...
ORGANISM(S): Homo sapiens 
2012-08-09 | E-GEOD-36238 | biostudies-arrayexpress
GenomicsTrachoma_GWAS_Unscarred_Controls
Gambian specimens with trachomatous scarring WHO grade C2/C3
EGAD00010000940 | EGA
GenomicsTrachoma_GWAS_Scarred_Cases
Gambian specimens without trachomatous scarring
EGAD00010000941 | EGA
GenomicsConjunctival fibrosis and the innate barriers to Chlamydia trachomatis intracellular infection: a genome wide association study
This data comes from a genome-wide association study in 1090 cases of scarring trachoma and 1531 controls from a non-selected multi-ethnic sampling of The Gambia. The data constitutes hard base calls at 1457295 features from the HumanOmni2.5-8 (Omni2.5) BeadChip. Three genotype-calling algorithms we...
EGAS00001001516 | EGA
GenomicsWellcome Trust Sanger Institute Data Sharing Policy for Trachoma GWAS
Data Access Committee EGAC00001000489
EGAC00001000489 | EGA
GenomicsSMG
Severe malaria cases from Gambia
EGAD00000000018 | EGA
GenomicsCBC
Cord blood control samples from Gambia
EGAD00000000017 | EGA
GenomicsMalariaGEN case-control study in the Gambia
MalariaGEN case-control study in the Gambia.
EGAS00000000026 | EGA
GenomicsMalariaGEN data access committee
Access to individual-level genotype data is available by application to the MalariaGEN Independent Data Access Committee. Access to data will be granted to qualified investigators for appropriate use. For further information information on data release policy and data access application form, please...
EGAC00000000002 | EGA
Sort   by:  
 Page size